Finland· FI-REL-REL22594
Fucicort Lipid
A betamethason und antibiotika product containing fusidic acid hemihydrate + betamethasone valerate, registered in Finland by Leo Pharma A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Betamethason und antibiotika is registered in 9 of 19 countries.
Countries holding a registration under ATC D07CC01 (betamethason und antibiotika), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Betamethason und antibiotika · ATC D07CC01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Fusidic acid hemihydrate + Betamethasone valerate
- Manufacturer
- Leo Pharma A/S
- Country
- Finland (FI)
- ATC code
- D07CC01
- ATC class
- Betamethason und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethason und antibiotika in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Fusidinsäure Plus Betamethason Dermapharm
- Germany · Fucicort, Fusicutan Plus Betamethason
- Croatia · Fusicutan Plus
- Italy · Fusicutanbeta
- Poland · Fusicutan Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6c492eb3-5d7f-455b-9a9c-c9d46c6abac0 GET /v1/drugs/6c492eb3-5d7f-455b-9a9c-c9d46c6abac0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "emulsiovoide",
"route": null,
"ddd_unit": null,
"strength": "20 mg/g + 1 mg/g",
"atc_label": "beetametasoni ja antibiootit",
"ma_number": "20084",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL22594",
"authorised_at": "2006-10-24"
}See everything about betamethason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.